Shopping Cart
- Remove All
Your shopping cart is currently empty
PF-5190457
Catalog No. T16508Cas No. 1334782-79-4
Alias PF-05190457
PF-5190457 is an effective and selective ghrelin receptor inverse agonist (pKi: 8.36).
PF-5190457
Catalog No. T16508Alias PF-05190457Cas No. 1334782-79-4
PF-5190457 is an effective and selective ghrelin receptor inverse agonist (pKi: 8.36).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $31 | In Stock | |
| 2 mg | $44 | In Stock | |
| 5 mg | $72 | In Stock | |
| 10 mg | $128 | In Stock | |
| 25 mg | $289 | In Stock | |
| 50 mg | Inquiry | In Stock | |
| 1 mL x 10 mM (in DMSO) | $82 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "PF-5190457"
Anamorelin
RC-1291, ONO-7643
T10319249921-19-5
Anamorelin (ONO-7643) is a novel ghrelin receptor agonist (EC50: 0.74 nM in the FLIPR assay).
- $55
Size
QTY
Ibutamoren Mesylate
MK-677, MK-0677
T7112159752-10-0
Ibutamoren Mesylate (MK-0677) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.
- $57
Size
QTY
NF-56-EJ40 hydrochloride
T12216L2728500-80-7In house
NF-56-EJ40 hydrochloride is a potent, high-affinity, and highly selective human SUCNR1 (GPR91) antagonist with an IC50 of 25 nM and a Ki of 33 nM, and shows almost no activity towards rat SUCNR1. NF-56-EJ40 hydrochloride has high affinity for humanized rat SUCNR1 with a Ki value of 17.4 nM.
- $50
Size
QTY
L-692429
MK-0751
T11798145455-23-8In house
L-692429 (MK-0751) is a potent nonpeptidyl growth hormone secretagogue (GHS) agonist and benzolactam derivative, known for reversing glucocorticoid-induced inhibition of GH secretion. L-692429 exhibits high affinity for the G protein-coupled receptor and is useful in studying acromegaly and obesity.
- $158
Size
QTY
Cortistatin-8 acetate
Cortistatin-8 acetate(485803-62-1 Free base)
TP2236L
Cortistatin-8 acetate is a corticosteroid analog, a GHS-R antagonist with inhibitory effects on the growth hormone pro-secretin receptor.Cortistatin-8 acetate is a synthetic corticosteroid-derived ligand for the growth hormone-releasing peptide receptor and does not alter the endocrine response to acylated growth hormone-releasing peptide or hesperidin in humans.Cortistatin-8 acetate is a synthetic corticosteroid-derived ligand for the growth hormone-releasing peptide receptor.
- $240
Size
QTY
TM-N1324
T171031144477-35-9
TM-N1324 is a GPR39 agonist. TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively. TM-N1324 has similar potencies to murine GPR39 with EC50s of 180 nM and 5 nM, respectively.
- $44
Size
QTY
CJC-1295 acetate(863288-34-0 free base)
DAC:GRF acetate
TP2328L
CJC-1295 acetate(863288-34-0 free base) (DAC:GRF acetate) is a synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS)
- $80
Size
QTY
Capromorelin Tartrate
CP 424391-18
TQ0022193273-69-7
Capromorelin Tartrate (CP 424391-18) is a potent, orally active growth hormone secretagogue receptor (GHSR) agonist (Ki: 7 nM for hGHS-R1a).
- $33
Size
QTY
AnaMorelin hydrochloride
RC-1291 hydrochloride, ONO-7643 hydrochloride
T7225861998-00-7
AnaMorelin hydrochloride (RC-1291 hydrochloride) is a novel ghrelin receptor agonist(EC50 : 0.74 nM, in the FLIPR assay).
- $30
Size
QTY
YIL 781
T23543875258-85-8
YIL 781 is a selective ghrelin receptor antagonist (GHS-R1a) (Ki = 17 nM), showing a weak affinity for kinesin receptors (K = 6 μM). YIL 781 improves glucose homeostasis in vivo and in vitro by blocking ghrelin secretion.
- $44
Size
QTY
hGPR91 antagonist 1
T115601314796-00-3
hGPR91 antagonist 1 is a potent and selective hGPR91 antagonist (IC50: 7 μM).
- $87
Size
QTY
TC-G-1008
GPR39-C3
T46481621175-65-2
TC-G-1008 (GPR39-C3) is a zinc receptor agonist with EC50 values of 0.4 nM for rat GPR39 and 0.8 nM for human GPR39.
- $41
Size
QTY
Select Batch
Purity:99.34%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | PF-5190457 is an effective and selective ghrelin receptor inverse agonist (pKi: 8.36). |
| Targets&IC50 | Ghrelin receptor:8.36 (pKi) |
| In vitro | PF-5190457 demonstrates an optimal balance of ghrelin receptor pharmacology along with off-target selectivity [1]. |
| In vivo | In human whole and dispersed islets, PF-5190457 has excellent selectivity and demonstrates robust increases in glucose-stimulated insulin secretion[1]. |
| Alias | PF-05190457 |
| Molecular Weight | 512.67 |
| Formula | C29H32N6OS |
| Cas No. | 1334782-79-4 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 250 mg/mL (487.64 mM), Sonication is recommended. Ethanol: 100 mg/mL (195.06 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy PF-5190457 | purchase PF-5190457 | PF-5190457 cost | order PF-5190457 | PF-5190457 chemical structure | PF-5190457 in vivo | PF-5190457 in vitro | PF-5190457 formula | PF-5190457 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.